The Cost of Blindness in the Republic of Ireland 2010-2020.

Green, D; Ducorroy, G; McElnea, E; Naughton, A; Skelly, A; O'Neill, C; Kenny, D; Keegan, D

Green, D; Ducorroy, G; McElnea, E; Naughton, A; Skelly, A; O'Neill, C; Kenny, D; Keegan, D.

Afiliação

Green D; Novartis Ireland, Merrion Road, Dublin, Ireland; J. E. Cairnes School of Business and Economics, National University of Ireland, Galway, Ireland.
Ducorroy G; Novartis Ireland, Merrion Road, Dublin, Ireland.
McElnea E; Ophthalmology Department, Mater Misericordiae University Hospital, Dublin, Ireland.
Naughton A; Ophthalmology Department, Mater Misericordiae University Hospital, Dublin, Ireland.
Skelly A; Novartis Ireland, Merrion Road, Dublin, Ireland.
O'Neill C; J. E. Cairnes School of Business and Economics, National University of Ireland, Galway, Ireland.
Kenny D; National Council for the Blind of Ireland, Whitworth Road, Dublin, Ireland.
Keegan D; Ophthalmology Department, Mater Misericordiae University Hospital, Dublin, Ireland; National Council for the Blind of Ireland, Whitworth Road, Dublin, Ireland.

J Ophthalmol ; 2016: 4691276, 2016.

Article em En | MEDLINE | ID: mdl-26981276

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Idioma: En Revista: J Ophthalmol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Irlanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google